Invited Commentary: Theoretical Considerations and Real-World Challenges for Research on Proxy Exposures and Ovarian Reserve

2020 ◽  
Vol 190 (1) ◽  
pp. 125-128
Author(s):  
Brian W Whitcomb

Abstract In this issue of the Journal, Upson et al. (Am J Epidemiol. 2021;190(1):116–124) assess urinary cadmium level as a potential environmental influence on ovarian reserve, as measured using serum follicle-stimulating hormone, in data from 1,681 US women (1988–1994). They compare 3 methods for modeling urinary proxy exposures—standardization, covariate adjustment, and covariate-adjusted standardization. Observing positive associations with all 3 approaches but higher-magnitude estimates using covariate adjustment as compared with standardization and covariate-adjusted standardization—proposed to be the result of collider-stratification bias—the authors conclude that cadmium may affect ovarian aging, and they recommend careful consideration of modeling approach. Comparisons of methodology in practice using real data are not straightforward, and additional complication arises from using a proxy outcome—serum follicle-stimulating hormone level to represent diminished ovarian reserve. In this commentary, I describe the theoretical basis for approaches for modeling urinary proxy exposures; consider potential explanations for why the approaches may yield different results in practice and describe why measurement error may play a larger role than collider-stratification bias; discuss challenges related to studies of ovarian reserve; and emphasize the importance of addressing both theoretical concerns and real-world challenges in methodological research and epidemiologic studies of ovarian reserve.

Author(s):  
Kaitlin R Karl ◽  
Fermin Jimenez-Krassel ◽  
Emily Gibbings ◽  
Janet L H Ireland ◽  
Zaramasina L Clark ◽  
...  

Abstract When women with small ovarian reserves are subjected to assisted reproductive technologies, high doses of gonadotropins are linked to high oocyte and embryo wastage and low live birth rates. We hypothesized that excessive follicle-stimulating hormone (FSH) doses during superovulation are detrimental to ovulatory follicle function in individuals with a small ovarian reserve. To test this hypothesis, heifers with small ovarian reserves were injected twice daily for 4 days, beginning on Day 1 of the estrous cycle with 35, 70, 140, or 210 IU doses of Folltropin-V (FSH). Each heifer (n = 8) was superovulated using a Williams Latin Square Design. During each superovulation regimen, three prostaglandin F2α injections were given at 12-h interval, starting at the seventh FSH injection to regress the newly formed corpus luteum (CL). Human chorionic gonadotropin was injected 12 h after the last (8th) FSH injection to induce ovulation. Daily ultrasonography and blood sampling were used to determine the number and size of follicles and corpora lutea, uterine thickness, and circulating concentrations of estradiol, progesterone, and anti-Müllerian hormone (AMH). The highest doses of FSH did not increase AMH, progesterone, number of ovulatory-size follicles, uterine thickness, or number of CL. However, estradiol production and ovulation rate were lower for heifers given high FSH doses compared to lower doses, indicating detrimental effects on ovulatory follicle function.


Sign in / Sign up

Export Citation Format

Share Document